Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Blue Water Vaccines has signed an agreement with Ology Bioservices to manufacture a novel universal influenza vaccine.
read more
Wednesday, November 29, 2017
bluebird bio has acquired a 125,000-square foot manufacturing facility in Durham, North Carolina.
read more
Thursday, August 23, 2018
bluebird bio and Gritstone Oncology announced a collaboration to research, develop and commercialize products for the treatment of cancer using cell therapy.
read more
Tuesday, February 21, 2012
Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal ...
read more
Boehringer Ingelheim announced today an agreement with Servier and its partner XOMA Corporation (Nasdaq: XOMA) to transfer XOMA’s technology and process for the commercial manufacture of gevokizumab, XOMA’s novel interleukin 1-beta (IL-1ß) allosteric...
read more
Tuesday, October 31, 2017
Boehringer Ingelheim and Sarah Cannon Research Institute announced an expansion of their partnership to develop novel immuno-oncology therapies
read more
Tuesday, November 11, 2014
Boehringer Ingelheim, one of the top 20 global pharma companies, has introduced IDBS’ [2]E-WorkBook Suite to eliminate data silos in the lab. The cross-domain platform has initially been deployed in North America with the next roll-out planned for ...
read more
Boehringer Ingelheim has signed with Zhangjiang Biotech & Pharmaceutical Base Development Company in Pudong, Shanghai a strategic alliance agreement and contract to build a cGMP biopharmaceuticals facility. The new site will provide full range of ...
read more
Wednesday, February 11, 2015
Boehringer Ingelheim, a research-based, global pharmaceutical company, and VTU Technology, a leading contract research and development company, announced today the renewal of their global Pichia pastoris technology collaboration agreement. VTU ...
read more
Bora has announced the appointment of four business development directors to its commercial teams in the US and Taiwan.
read more
Bora Pharmaceuticals has announced the appointment of four business development directors to its commercial teams in the US and Taiwan.
read more
Monday, November 25, 2019
Bora has announced the appointment of Sam Ricchezza as President of North American operations.
read more
Wednesday, December 04, 2019
Bora has announced the appointment of Samuel Ricchezza as President of North America Operations.
read more
Tuesday, December 15, 2020
Bora announced the CDMO has successfully completed the acquisition of GSK’s Mississauga, Ontario facility.
read more
Thursday, September 15, 2022
Fast-growing contract development and manufacturing organization (CDMO), Bora Pharmaceuticals, has completed the acquisition of TWi Pharmaceutical Co.Ltd, a technology-based company specializing in development and commercialization of niche generic ...
read more